C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/202, 167/220
C07D 487/14 (2006.01) A61K 31/505 (2006.01) A61K 31/70 (2006.01) C07H 19/04 (2006.01)
Patent
CA 2013381
Adenosine analogues which act selectively at adenosine receptors and which act in general as adenosine antagonists are disclosed. From in vitro studies it is known that specific physiological effects can be distinguished as a result of this selectivity and that adenosine receptor activity in vitro correlates with adenosine receptor activity in vivo. Pharmaceutical preparations of the subject compounds of FORMULA I (see formula I) can be prepared on the basis of the selective binding activity of the compounds disclosed herein which can be expected to enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.
Lentz Nelsen L.
Peet Norton P.
Merrell Dow Pharmaceuticals (canada) Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
Selective adenosine receptor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective adenosine receptor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective adenosine receptor compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1348101